Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

This study has been completed.
Sponsor:
Information provided by:
Cubist Pharmaceuticals Holdings LLC
ClinicalTrials.gov Identifier:
NCT00538694
First received: October 1, 2007
Last updated: July 16, 2015
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2001
  Primary Completion Date: September 2001 (Final data collection date for primary outcome measure)